Join us for an in-depth webinar that challenges the overreliance on sugammadex alone and spotlights the indispensable role of quantitative train-of-four (TOF) monitoring in optimizing patient care.

What you will learn

• How quantitative train-of-four monitoring can help tailor sugammadex dosing to individual patient needs.
• Evidence indicating that a majority of patients receive an improper dose—some too much, others too little.
• The potential adverse events associated with sugammadex use and strategies to mitigate these risks.
• Best practices and real-world applications from both U.K. and U.S. experts to optimize patient safety.

Presenters

• Dr. Ross Renew (U.S)
• Dr. Grant Rodney (U.K.)

Moderator

Michael Noble
VP, Global Marketing, Senzime
 

Sign up for webinar